Literature DB >> 14618092

The protective effects of monophosphoryl lipid A on the ischemic myocardium and endothelium in rats.

Hui-Qing Zhu1, Jun-Lin Jiang, Rong Lu, Xiao-Hong Zhang, Han-Wu Deng, Yuan-Jian Li.   

Abstract

Previous investigations have shown that a single dose of low-density lipoprotein (LDL) injection causes a marked decrease in endothelium-dependent relaxation, and that endothelial dysfunction aggravates myocardial injury due to ischemia-reperfusion in atherosclerotic animals. Monophosphoryl lipid A-induced delayed preconditioning preserves the ischemic myocardium and endothelial cells. The objective of the present study was to examine the effect of monophosphoryl lipid A on endothelial function and ischemia-reperfusion-induced myocardial injury in the rats treated with LDL. A single injection of native LDL (4 mg/kg, i.v.) caused a significant decrease in vasodilator responses to acetylcholine and an increase in the serum level of asymmetric dimethylarginine, the endogenous nitric oxide synthase inhibitor. Pretreatment with monophosphoryl lipid A (300 or 450 microg/kg, i.p.) significantly improved endothelium-dependent relaxation and decreased concentrations of asymmetric dimethylarginine, and the effects of monophosphoryl lipid A were attenuated by L-nitro-arginine-methylester, but not by aminoguanidine. LDL treatment only aggravated the decreased coronary flows but did not affect cardiac dysfunction due to ischemia-reperfusion in the rats treated with LDL. Pretreatment with monophosphoryl lipid A significantly improved cardiac dysfunction by ischemia-reperfusion in the rats treated with or without LDL, an effect that was abolished by aminoguanidine. The present study suggests that: (1) a single injection of native LDL causes a decrease in endothelium-dependent relaxation, and aggravates the decrease of coronary flow due to ischemia-reperfusion, (2) pretreatment with monophosphoryl lipid A protects the myocardium against ischemia-reperfusion in the rats treated with or without native LDL, and (3) the protective effect of monophosphoryl lipid A on endothelial cells is related to reduction of asymmetric dimethylarginine level.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14618092     DOI: 10.1023/a:1027335321530

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  1 in total

1.  Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.

Authors:  Chelsea A Embry; Luigi Franchi; Gabriel Nuñez; Thomas C Mitchell
Journal:  Sci Signal       Date:  2011-05-03       Impact factor: 8.192

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.